Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer

被引：0
|
作者：
D'Amico, AV [1 ]
机构：
[1] Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA 02215 USA
来源：
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词：
D O I：
暂无
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：380 / 389
页数：10
相关论文
共 50 条
  • [41] 18-YEAR PROSTATE CANCER-SPECIFIC MORTALITY AFTER PROSTATECTOMY, BRACHYTHERAPY, EXTERNAL BEAM RADIATION THERAPY, HORMONAL THERAPY, OR MONITORING FOR LOCALIZED PROSTATE CANCER
    Herlemann, Annika
    Cowan, Janet E.
    Washington, Samuel L., III
    Broering, Jeanette M.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    JOURNAL OF UROLOGY, 2019, 201 (04) : E737 - E738
  • [42] 18-year prostate cancer-specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer
    Herlemann, Annika
    Cowan, Janet E.
    Washington, Samuel L.
    Wong, Anthony C.
    Broering, Jenny M.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [43] Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer
    Herlemann, Annika
    Cowan, Janet E.
    Washington, Samuel L.
    Wong, Anthony C.
    Broering, Jeanette M.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    EUROPEAN UROLOGY, 2024, 85 (06) : 565 - 573
  • [44] Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent
    Kattan, Michael W.
    Cuzick, Jack
    Fisher, Gabrielle
    Berney, Daniel M.
    Oliver, Tim
    Foster, Christopher S.
    Moller, Henrik
    Reuter, Victor
    Fearn, Paul
    Eastham, James
    Scardino, Peter T.
    CANCER, 2008, 112 (01) : 69 - 74
  • [45] SURVIVAL OUTCOMES FOLLOWING SURGERY OR RADIATION FOR LOCALIZED PROSTATE CANCER: RESULTS FROM THE PROSTATE CANCER OUTCOMES STUDY
    Hoffman, Richard
    Koyama, Tatsuki
    Fan, Kang-Hsien
    Albertsen, Peter
    Goodman, Michael
    Hamilton, Ann
    Stanford, Janet
    Stroup, Antoinette
    Penson, David
    JOURNAL OF UROLOGY, 2012, 187 (04) : E280 - E280
  • [46] SERUM PROSTATE-SPECIFIC ANTIGEN AFTER RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER - PROGNOSTIC IMPLICATIONS
    KAVADI, VS
    ZAGARS, GK
    POLLACK, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02): : 279 - 287
  • [47] Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
    Onita Bhattasali
    Leonard N Chen
    Jennifer Woo
    Jee-Won Park
    Joy S Kim
    Rudy Moures
    Thomas Yung
    Siyuan Lei
    Brian T Collins
    Keith Kowalczyk
    Simeng Suy
    Anatoly Dritschilo
    John H Lynch
    Sean P Collins
    Radiation Oncology, 9
  • [48] A METHOD FOR DETERMINING A PROSTATE-SPECIFIC ANTIGEN CURE AFTER RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    DAMICO, AV
    WHITTINGTON, R
    MALKOWICZ, SB
    SCHULTZ, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 473 - 477
  • [49] Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer - Discussion
    Carroll, PR
    D'Amico, A
    Malkowicz, SB
    Gleave, ME
    Bubley, GJ
    UROLOGY, 2001, 58 (2A) : 82 - 82
  • [50] ESTIMATING PROSTATE CANCER RELATIVE SURVIVAL AND CANCER-SPECIFIC DEATH
    Morrell, Christopher H.
    Kattan, Michael W.
    MacKintosh, F. Roy
    Van den Eeden, Stephen
    Neville, Thomas B.
    ADVANCES AND APPLICATIONS IN STATISTICS, 2015, 46 (03) : 197 - 223
12345